Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Clinical trial NCT02788981 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02788981
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2022-12-21
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.